Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CD44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PAIP2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIAE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MDGA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01420 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GPAM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYRIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B4GALT6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APLP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RABEP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OIP5-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MINA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC5A12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
URI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDAH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCUN1D4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on